A systematic literature review of clinical trials and therapeutic applications of ibogaine.
Journal of Substance Abuse Treatment July 1, 2022 Patrick Köck, Katharina Froelich, Marc Walter et al. 68 citations
Iboga and its primary alkaloids, ibogaine and noribogaine, have been of interest to researchers and practitioners, mainly due to their putative efficacy in treating substance use disorders (SUDs). For many SUDs, still no effective pharmacotherapies exist. Distinct psychoactive and somatic effects of the iboga alkaloids set them apart from classic hallucinogens like LSD, mescaline, and...